Searched for
ASTRAZENECA LP
AstraZeneca gets $107 mln Pfizer verdict overturned in US cancer drug patent fightOn Wednesday, U.S. District Judge Matthew Kennelly invalidated Pfizer’s patents related to the cancer drug Nerlynx, overturning a jury's $1...- Granules India gets USFDA nod for generic drug used for short-term treatment of heartburnGranules India has received approval from the US Food & Drug Administration (USFDA) for its generic Esomeprazole Magnesium delayed-release ...
- Alembic Pharma gets USFDA nod for generic drug to treat breast cancerThe approval granted by the US Food & Drug Administration (USFDA) is for the abbreviated new drug application (ANDA), Fulvestrant injection...
- Oxford-AstraZeneca vaccine effective but questions remain for elderlyThe Lancet found that a vaccine developed by the University of Oxford and AstraZeneca Plc is safe and effective, more analysis will be need...
- European stock rally takes step back as tech, healthcare dragThe pan-European STOXX 600 declined 0.4%, as investors moved out of expensive names, while bidding up laggards such as banking, auto and oi...
- AstraZeneca approaches Gilead about potential mergerAstraZeneca Plc has approached rival drugmaker Gilead Sciences Inc. about a potential merger.
- Sebi censures Astrazeneca Pharma's promoter, Elliot GroupReason: professional misconduct and unfair trade practices during delisting plan in 2014.
- Stocks in the news: PFC, Bandhan Bank, YES Bank, DLF and InterGlobe AviationHere's a look at the top stocks that may hog the limelight in today's session.
- Lupin gets USFDA nod for Asthma drugQuoting IQVIA MAT September data, Lupin said, the said Asthma drug had annual sales of around USD 474.5 million in the US.
- Unichem Lab gets USFDA nod for schizophrenia tabletsUnichem Laboratories has received approval from the USFDA for its generic Quetiapine Fumarate tablets used for treatment of schizophrenia a...
- Cipla gains as partner Sandoz gets USFDA approval for generic drugCipla surged over 4% in trade after its partner Sandoz received a USFDA nod to launch a generic version of Pulmicort respules.
- US jury orders GlaxoSmithKline, Novartis to pay $114 mn price fraud caseA jury in Alabama on Tuesday found two major pharmaceutical companies defrauded Alabama in a long-running drug pricing scheme affecting a f...
Load More
